Published in J Acquir Immune Defic Syndr on January 01, 1991
Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol (1999) 2.07
Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol (2008) 1.02
Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94
Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infect Dis (2006) 0.83
Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report. BMC Infect Dis (2006) 0.79
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study. J Neurovirol (2017) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science (1990) 6.77
Paranasal sinus bony anatomic variations and mucosal abnormalities: CT analysis for endoscopic sinus surgery. Laryngoscope (1991) 5.34
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest (1989) 3.92
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (1993) 2.35
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol (1991) 2.17
Infrared emission detection tympanic thermometry may be useful in diagnosing acute otitis media. Am J Emerg Med (1995) 1.96
Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) (2001) 1.86
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (1989) 1.80
Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med (1993) 1.79
Clinical gnathostomiasis: case report and review of the English-language literature. Clin Infect Dis (1993) 1.77
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest (1989) 1.77
In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis (1995) 1.69
Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types. J Clin Invest (1991) 1.44
Lack of cerebrospinal fluid myelin basic protein in HIV-infected asymptomatic individuals with intrathecal synthesis of IgG. Neurology (1989) 1.40
Physician business cards enhance patient satisfaction. Am J Emerg Med (1994) 1.40
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1990) 1.28
Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons. JAMA (1993) 1.27
Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J Infect Dis (1996) 1.22
Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol (1988) 1.21
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology (2005) 1.17
International consensus for a definition of disease flare in lupus. Lupus (2010) 1.16
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. Science (1991) 1.14
Fluorescent staining for leukocyte chemotaxis. Eosinophil-specific fluorescence with aniline blue. J Immunol Methods (1988) 1.11
Effect of maternal race on outcome of preterm infants in the military. Pediatrics (1993) 1.10
Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. J Biol Chem (1987) 1.07
Kawasaki syndrome in an adult: case report and review of the literature in adolescents and adults. J Clin Rheumatol (2001) 1.07
Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J Invest Dermatol (1996) 1.06
Multidrug-resistant Corynebacterium striatum pneumonia in a heart transplant recipient. Transpl Infect Dis (2003) 1.06
Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis (1988) 1.04
Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts. J Infect Dis (1991) 1.04
Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch Neurol (1993) 1.03
Neurological aspects of antiphospholipid antibody syndrome. Lupus (1996) 1.02
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke. Stroke (1997) 1.00
Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol (1995) 1.00
Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals. Arch Neurol (1989) 0.98
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States. J Clin Microbiol (1992) 0.98
Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect Dis (1988) 0.98
Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection. Eur J Immunol (1991) 0.97
Influence of calcium acetate or calcium citrate on intestinal aluminum absorption. Kidney Int (1990) 0.96
Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees. J Virol (1990) 0.96
Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. J Immunol (1991) 0.96
Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects. J Infect Dis (1993) 0.96
Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med (1995) 0.95
Use of furcal bone sounding to improve accuracy of furcation diagnosis. J Periodontol (1994) 0.92
A chemotactic receptor for val(ala)-gly-ser-glu on human. Immunol Commun (1976) 0.92
Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients. J Infect Dis (1992) 0.92
The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet Gynecol (1992) 0.92
Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1. J Acquir Immune Defic Syndr (1992) 0.91
Accessory cell function in asymptomatic human immunodeficiency virus-infected patients. Clin Immunol Immunopathol (1990) 0.91
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications. Science (1991) 0.90
Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels. J Clin Immunol (1991) 0.90
Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis (1995) 0.90
Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunologic release, granule association, and demostration of structura heterogeneity. J Immunol (1978) 0.90
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus (2003) 0.89
Steroids for the treatment of corrosive esophageal injury: a statistical analysis of past studies. Am J Emerg Med (1992) 0.89
Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol (1981) 0.89
Brucella abortus stimulates human T cells from uninfected and HIV-infected individuals to secrete IFN gamma: implications for use of Brucella abortus as a carrier in development of human vaccines. AIDS Res Hum Retroviruses (1992) 0.89
Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease. Am Heart J (2001) 0.89
Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin Exp Rheumatol (1993) 0.88
Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. The Antiphospholipid Antibodies in Stroke Study Group. Stroke (1992) 0.87
Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. Eur J Immunol (1991) 0.87
Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin Infect Dis (2001) 0.87
The relationship of serum IgA concentration to human immunodeficiency virus (HIV) infection: a cross-sectional study of HIV-seropositive individuals detected by screening in the United States Air Force. J Allergy Clin Immunol (1988) 0.87
Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol (1995) 0.87
Validating a computerized neuropsychological test battery for mixed ethnic lupus patients. Lupus (2003) 0.86
Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. J Infect Dis (1986) 0.86
Serum IgE levels in 622 persons with human immunodeficiency virus infection: IgE elevation with marked depletion of CD4+ T-cells. AIDS Res Hum Retroviruses (1990) 0.85
Infection, apoptosis, and killing of mature human eosinophils by human immunodeficiency virus-1. Am J Respir Cell Mol Biol (1995) 0.84
Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology (1995) 0.84
Acute hemodynamic and respiratory effects of amniotic fluid embolism in the pregnant goat model. Am J Obstet Gynecol (1993) 0.84
Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia. J Allergy Clin Immunol (1993) 0.83
Early lymphocyte transformation abnormalities in human immunodeficiency virus infection. J Clin Immunol (1989) 0.83
Assessment of a multistage therapeutic community for drug-involved offenders. J Psychoactive Drugs (1995) 0.83
Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus (2010) 0.83
Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Clin Exp Immunol (1990) 0.82
Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection. J Acquir Immune Defic Syndr (1991) 0.82
Psychiatric illness at all stages of human immunodeficiency virus infection. Am J Psychiatry (1988) 0.81
Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection. Adv Exp Med Biol (1991) 0.81
Age-adjusted CD4+ lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus. The Military Pediatric HIV Consortium. Clin Infect Dis (1993) 0.81
Neuromyelitis optica: two new cases and review of the literature. J Clin Neuroophthalmol (1985) 0.81
Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation. Stroke (1996) 0.80
High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.80
Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol (1988) 0.80
Preventive HIV type 1 vaccine clinical trials: a regulatory perspective. AIDS Res Hum Retroviruses (1998) 0.79
Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. AIDS (1991) 0.79